Statute Details
- Title: Medicines (Veterinary Medicinal Products) (Exemption) Order
- Act Code: MA1975-OR1
- Legislation Type: Subsidiary Legislation (SL)
- Authorising Act: Medicines Act (Chapter 176, Section 9)
- Citation / G.N.: G.N. No. S 143/1977
- Revised Edition: Revised Edition 2000 (31 January 2000)
- Commencement Date: Not stated in the extract (Order dated 24 June 1977)
- Key Provisions (from extract): Section 1 (Citation); Section 2 (Exemption)
- Status: Current version as at 27 March 2026
What Is This Legislation About?
The Medicines (Veterinary Medicinal Products) (Exemption) Order is a short piece of subsidiary legislation made under the Medicines Act (Chapter 176). Its central purpose is to carve out a specific exemption for veterinary medicinal products from a particular regulatory prohibition in the Medicines Act.
In plain language, the Order addresses a narrow question: when the Medicines Act restricts certain activities relating to “medicinal products” (including manufacture and wholesale dealing), does that restriction apply equally to veterinary medicinal products? This Order answers “no” for at least one key prohibition. Specifically, it provides that the prohibition in Section 6 of the Medicines Act does not apply to veterinary medicinal products.
For practitioners, the practical effect is that certain compliance obligations and enforcement risks that attach to medicinal products under the Medicines Act may not attach—at least not via Section 6—to veterinary medicinal products. However, because the Order is an exemption from one specific prohibition, it does not necessarily mean that veterinary medicinal products are unregulated in all respects. Other provisions of the Medicines Act (and any other subsidiary legislation) may still apply.
What Are the Key Provisions?
Section 1 (Citation) is a standard provision that allows the Order to be referred to by its short title. While it is not substantive, it is important for legal drafting and citation in compliance documentation, correspondence with regulators, and court or tribunal filings.
Section 2 (Exemption) is the operative provision. It states that Section 6 of the Act (prohibition against manufacture and wholesale dealing of medicinal product) shall not apply to veterinary medicinal products. This is the entire substantive content of the Order in the extract provided.
To understand the legal significance, it is necessary to read Section 2 together with the Medicines Act’s Section 6. Although the extract does not reproduce Section 6, the description in the Order indicates that Section 6 contains a prohibition targeting two activities: (i) manufacture and (ii) wholesale dealing of a medicinal product. The exemption therefore removes the Section 6 prohibition as a barrier for veterinary medicinal products.
What this means in practice is that, for veterinary medicinal products, the specific prohibition on manufacture and wholesale dealing in Section 6 is not triggered. This can affect how businesses structure their operations (for example, whether they can manufacture or wholesale veterinary medicinal products without being constrained by that particular prohibition). It may also affect enforcement strategy: regulators cannot rely on Section 6 to stop manufacture or wholesale dealing of veterinary medicinal products, because the Order expressly excludes them from Section 6’s scope.
Important interpretive points follow from the wording. First, the exemption is tied to “veterinary medicinal products.” The legal analysis will therefore turn on how “veterinary medicinal products” is defined in the Medicines Act or related instruments. If a product is borderline—e.g., used for animals but marketed or regulated differently—classification becomes critical. Second, the exemption is limited to Section 6. It does not automatically exempt veterinary medicinal products from all other Medicines Act controls (such as licensing, quality requirements, advertising restrictions, or other prohibitions), unless those other provisions are also exempted elsewhere.
How Is This Legislation Structured?
This Order is extremely concise and consists of two sections:
(1) Section 1: Citation. It provides the short title of the Order.
(2) Section 2: Exemption. It states that Section 6 of the Medicines Act does not apply to veterinary medicinal products.
There are no schedules, definitions, or procedural provisions in the extract. As a result, the legal work for practitioners is largely interpretive: identifying the scope of “veterinary medicinal products,” mapping Section 6’s prohibition to the business activities in question, and determining whether any other regulatory requirements still apply.
Who Does This Legislation Apply To?
The exemption applies to activities involving veterinary medicinal products. In practical terms, it is relevant to persons and entities that would otherwise be caught by the Medicines Act’s prohibition on manufacture and wholesale dealing of medicinal products—such as manufacturers, wholesalers, distributors, and potentially importers or supply-chain actors depending on how “wholesale dealing” is interpreted under the Medicines Act.
However, the Order does not create a blanket permission for all conduct. It only removes the applicability of Section 6. Therefore, while the exemption may benefit businesses seeking to manufacture or wholesale veterinary medicinal products, they still need to assess whether other provisions of the Medicines Act or other subsidiary legislation impose licensing, registration, quality assurance, storage, labelling, or other compliance obligations.
From a risk-management perspective, lawyers advising regulated businesses should treat this Order as a targeted relief instrument rather than a general deregulation measure. The exemption’s narrowness is both its value and its limitation.
Why Is This Legislation Important?
Although the Order is short, it can have significant commercial and regulatory implications. The Medicines Act’s prohibition on manufacture and wholesale dealing is a powerful compliance lever. By excluding veterinary medicinal products from Section 6, the Order reduces the regulatory friction that would otherwise apply to those activities.
For regulated entities, this can affect:
- Regulatory strategy: businesses may focus on satisfying other statutory requirements rather than treating Section 6 as a hard prohibition.
- Contracting and supply arrangements: parties may structure agreements for manufacturing and wholesale supply with a clearer understanding that Section 6 is not a basis for prohibition for veterinary medicinal products.
- Enforcement posture: regulators cannot invoke Section 6 to stop manufacture or wholesale dealing of veterinary medicinal products, though they may still rely on other provisions.
For practitioners, the key legal importance is the scope of the exemption. The Order does not say that veterinary medicinal products are exempt from the Medicines Act entirely. It only exempts them from the specific prohibition in Section 6. This means that legal advice must be granular: identify the exact activity (manufacture vs wholesale dealing), identify the product category (veterinary medicinal product), and then cross-check other statutory and regulatory requirements that may still apply.
Finally, because the Order is currently in force (as at 27 March 2026) and has a legislative history dating back to 1977 with a revised edition in 2000, it is likely to remain a stable part of the regulatory framework. Businesses operating in the veterinary medicines space should therefore incorporate this exemption into their compliance matrices and legal risk assessments.
Related Legislation
- Medicines Act (Chapter 176) — in particular, Section 6 (prohibition against manufacture and wholesale dealing of medicinal product) and Section 9 (authorising provision for subsidiary legislation)
Source Documents
This article provides an overview of the Medicines (Veterinary Medicinal Products) (Exemption) Order for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.